Home   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
VDA
  >   Verteporfin
Verteporfin Chemical Structure

Verteporfin

Data Sheet For research use only. Not for human use.
Cat. No. :BCP04238CAS No. :129497-78-5Purity:98%
 Tel: 0086-13026320035   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Chemical Properties&Biological Activity
CAS No. 129497-78-5 Cat. No. BCP04238
Name Verteporfin
Synonyms CL 318952;CL318952;CL-318952;
SMILES
Chemical Name
Formula C41H42N4O8 M. Wt 718.79
Purity 98% Storage Store at 4-8°C
Description Verteporfin (trade name Visudyne), a benzoporphyrin derivative, is a medication used as a photosensitizer for photodynamic therapy to eliminate the abnormal blood vessels in the eye associated with conditions such as the wet form of macular degeneration. Verteporfin accumulates in these abnormal blood vessels and, when stimulated by nonthermal red light with a wavelength of 693 nm in the presence ofoxygen, produces highly reactive short-lived singlet oxygen and other reactive oxygen radicals, resulting in local damage to theendothelium and blockage of the vessels. Verteporfin is also used off-label for the treatment of central serous retinopathy. Verteporfin is given intravenously, 15 minutes before laser treatment. Most common side effects are, blurred vision, headache, and local effects at the injectionsite. Also, photosensitivity; it is advised to avoid exposure to sunlight and unscreened lighting until 48 hours after the injection of verteporfin. None known. Verteporfin has no infl
  • Quality Control&Technical Support
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:Verteporfin supplier,Verteporfin purchase,Verteporfin manufacturer,Verteporfin distributor,Verteporfin cost,Verteporfin buy,Verteporfin for sale

0086-13720134139